{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:18:49Z","timestamp":1760833129848,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.bmcl.2022.128904","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T02:20:35Z","timestamp":1658197235000},"page":"128904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulators"],"prefix":"10.1016","volume":"73","author":[{"given":"Leda","family":"Ivanova Bencheva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Donnici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"Prandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Sinisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilenia","family":"De Matteo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Randazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Conti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Di Lucia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Bono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Giustini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Vittoria Orsale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Patsilinakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Monteagudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Iannacone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Summa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca G.","family":"Guidotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"De Francesco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romano","family":"Di Fabio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2022.128904_b0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","article-title":"Immunobiology and pathogenesis of hepatitis B virus infection","volume":"22","author":"Iannacone","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bmcl.2022.128904_b0010","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3350\/cmh.2018.0106","article-title":"Unmet need in chronic hepatitis B management","volume":"25","author":"Liang","year":"2019","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.bmcl.2022.128904_b0015","unstructured":"World Health Organization (WHO) web site. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"10.1016\/j.bmcl.2022.128904_b0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2015.61.5724","article-title":"Infection and cancer: the case of hepatitis B","volume":"34","author":"Chan","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bmcl.2022.128904_b0025","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.3390\/v7092854","article-title":"Anti-HBV drugs, progress, unmet needs, and new hope","volume":"7","author":"Kang","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.bmcl.2022.128904_b0030","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2468-1253(19)30119-0","article-title":"A Global Scientific Strategy to Cure hepatitis B","volume":"4","author":"Revill","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.bmcl.2022.128904_b0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/cld.904","article-title":"Development of hepatocellular carcinoma in patients with suppressed viral replication: changes in risk over time","volume":"15","author":"Udompap","year":"2020","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.bmcl.2022.128904_b0040","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepathitis B virus infection: towards a cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2022.128904_b0045","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1021\/acs.jmedchem.6b01442","article-title":"Current, and future developments of therapeutic agents for treatment of chronic hepatitis B virus infection","volume":"60","author":"Pay","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128904_b0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cbpa.2019.02.009","article-title":"Recent advances in the development of HBV capsid assembly modulators","volume":"50","author":"Nijampatnam","year":"2019","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.bmcl.2022.128904_b0055","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/acsinfecdis.8b00337","article-title":"Treatment of chronic hepatitis B virus infection using small molecule modulators of nucleocapsid assembly: recent advances and perspectives","volume":"5","author":"Lyang","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmcl.2022.128904_b0060","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1021\/acschembio.0c00320","article-title":"Local Stabilization of Subunit\u2212Subunit Contacts Causes Global Destabilization of Hepatitis B Virus Capsids","volume":"15","author":"Schlicksup","year":"2020","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmcl.2022.128904_b0065","first-page":"1","article-title":"Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2022.128904_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2020.104824","article-title":"Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential","volume":"180","author":"Xia","year":"2020","journal-title":"Antiv Res"},{"key":"10.1016\/j.bmcl.2022.128904_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01734-18","article-title":"Preclinical Characterization of NVR 3\u2013778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus","volume":"63","author":"Lam","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2022.128904_b0080","doi-asserted-by":"crossref","first-page":"15196","DOI":"10.1073\/pnas.1513803112","article-title":"High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein","volume":"112","author":"Klumpp","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.bmcl.2022.128904_b0085","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1021\/ci300604z","article-title":"Lessons Learned in Empirical Scoring with smina from the CSAR 2011 Benchmarking Exercise","volume":"53","author":"Koes","year":"2013","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmcl.2022.128904_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0155183","article-title":"Vinardo: A Scoring Function Based on Autodock Vina Improves Scoring, Docking, and Virtual Screening","volume":"11","author":"Quiroga","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmcl.2022.128904_b0095","unstructured":"The PyMOL Molecular Graphics System, Version 2.0 Schr\u00f6dinger, LLC."},{"key":"10.1016\/j.bmcl.2022.128904_b0100","doi-asserted-by":"crossref","unstructured":"Ni Y, Urban S. Hepatitis B Virus Infection of HepaRG Cells, HepaRG-hNTCP Cells, and Primary Human Hepatocytes. In Hepatitis B Virus: Methods and Protocols vol. 1540 Guo H, Cugonati A. Eds.; SpringerLink. 2017; pp 15-25.","DOI":"10.1007\/978-1-4939-6700-1_2"},{"key":"10.1016\/j.bmcl.2022.128904_b0105","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/jac\/dkaa179","article-title":"Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136379 across full-length genotype A-H clinical isolates and core site-directed mutants in vitro","volume":"75","author":"Verbinnen","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmcl.2022.128904_b0110","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.3390\/biomedicines9111577","article-title":"The Hepatitis B Virus Nucleocapsid-Dynamic Compartment for Infectious Virus Production and New Antiviral Target","volume":"9","author":"Niklasch","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.bmcl.2022.128904_b0115","unstructured":"In the Ames test compound 10 did not induce reverse mutation in Salmonella typhimurium or Escherichia coli in the absence or presence of metabolism indued by S9 up to 1250 \u00b5g\/plate concentration."},{"key":"10.1016\/j.bmcl.2022.128904_b0120","unstructured":"This study was conducted in full compliance with the EU Directive 63\/2010 (On the Protection of Animals used for Scientific Purposes) and its Italian transposition (Italian Decree no. 26\/2014) as well as with all applicable Italian legislation and guidelines. IRBM is authorized by the Italian Ministry of Health and by local veterinary authority to house, breed and use laboratory rodents for scientific purposes."},{"key":"10.1016\/j.bmcl.2022.128904_b0125","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1128\/jvi.69.10.6158-6169.1995","article-title":"High-level hepatitis B virus replication in transgenic mice","volume":"69","author":"Guidotti","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.bmcl.2022.128904_b0130","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/j.gastro.2017.10.017","article-title":"Efficacy of NVR 3\u2013778, Alone and in Combination With Pegylated Interferon, vs Entecavir in uPA\/SCID Mice With Humanized Livers and HBV Infection","volume":"154","author":"Klumpp","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bmcl.2022.128904_b0135","unstructured":"Bencheva, LI, De Francesco R, Donnici L et al. Discovery Process and Anti-HBV Profile of Novel Sulfamoyl Benzamide Derivatives as In Vitro and In Vivo Potent CpAM. Drug Discovery Chemistry Conference, P14, 2021."},{"key":"10.1016\/j.bmcl.2022.128904_b0140","unstructured":"All experimental animal procedures were approved by the Institutional Animal Committee of the San Raffaele Scientific Institute."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22003808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22003808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:47:42Z","timestamp":1760773662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X22003808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":28,"alternative-id":["S0960894X22003808"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128904","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulators","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128904"}}